CMMB
Chemomab Therapeutics Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$2.61
−6.79%0
Insider buys (3m)
2
Insider sells (3m)
-$6.5K
Net value (3m)
+79.5%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 1, 2026 | Cohen Neil Harris · director | Sale | 1,304 | $2.85 |
| Sep 1, 2026 | Cohen Neil Harris · director | A-Award | 5,172 | $2.14 |
| Sep 1, 2026 | Cohen Neil Harris · director | A-Award | 3,821 | $6.16 |
| Sep 1, 2026 | Cohen Neil Harris · director | A-Award | 2,520 | $2.96 |
| Sep 1, 2026 | Cohen Neil Harris · director | A-Award | 1,714 | $6.48 |
| Sep 1, 2026 | Cohen Neil Harris · director | A-Award | 1,705 | $14 |
| Sep 1, 2026 | Cohen Neil Harris · director | A-Award | 2,971 | $109 |
| Sep 1, 2026 | Cohen Neil Harris · director | A-Award | 172 | $53 |
| Sep 1, 2026 | Cohen Neil Harris · director | Sale | 1,000 | $2.80 |
| Jun 1, 2026 | Mor George Adi · director, officer: Chief Executive Officer | Purchase | 4,926 | $2.08 |
| Jun 1, 2026 | Mor George Adi · director, officer: Chief Executive Officer | Purchase | 4,878 | $2.05 |
| Jul 5, 2023 | Darvish Nissim · director | A-Award | 6,820 | $3.53 |
| Jul 5, 2023 | Darvish Nissim · director | A-Award | 10,123 | $0.80 |
| Jul 5, 2023 | Darvish Nissim · director | A-Award | 6,857 | $1.62 |
| Jul 5, 2023 | Darvish Nissim · director | A-Award | 11,884 | $27 |
| Jul 5, 2023 | Darvish Nissim · director | A-Award | 20,572 | $1.70 |
| Jun 20, 2023 | Quigley Jill M. · director | A-Award | 6,857 | $1.71 |
| Jun 20, 2023 | Quigley Jill M. · director | A-Award | 13,640 | $3.25 |
| Jun 16, 2023 | Fatal Sigal · officer: Chief Financial Officer | A-Award | 35,600 | $9.83 |
| Jun 16, 2023 | Fatal Sigal · officer: Chief Financial Officer | A-Award | 102,860 | $1.70 |
| Jun 16, 2023 | Fatal Sigal · officer: Chief Financial Officer | A-Award | 29,400 | $2.11 |
| Mar 23, 2023 | Nicaise Claude · director | A-Award | 11,884 | $27 |
| Mar 23, 2023 | Nicaise Claude · director | A-Award | 6,820 | $3.53 |
| Mar 23, 2023 | Nicaise Claude · director | A-Award | 6,857 | $1.62 |
| Jan 5, 2023 | Mor George Adi · officer: Chief Scientific Officer | A-Award | 33,725 | $0.00 |
| Jan 5, 2023 | OrbiMed Israel GP Ltd. · director | Sale | 266,376 | $3.34 |
| Jan 5, 2023 | OrbiMed Israel GP Ltd. · director | Sale | 70,524 | $4.51 |
| Jan 5, 2023 | Mor George Adi · officer: Chief Scientific Officer | Sale | 7,700 | $5.03 |
| Jan 5, 2023 | Mor George Adi · officer: Chief Scientific Officer | Sale | 6,100 | $5.03 |
| Jan 5, 2023 | Mor George Adi · officer: Chief Scientific Officer | A-Award | 131,698 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 5Increased 9Reduced 9Sold out 3
| Filer | Action | Shares | Filed |
|---|---|---|---|
| CITADEL ADVISORS LLC | Increased | 95,311 | Sep 2, 2026 |
| ADAR1 CAPITAL MANAGEMENT, LLC | Reduced | 80,000 | May 18, 2026 |
| ADAR1 Capital Management, LLC | Unchanged | 80,000 | Aug 14, 2026 |
| CITADEL ADVISORS LLC | Reduced | 64,182 | May 15, 2026 |
| KESTRA PRIVATE WEALTH SERVICES, LLC | Unchanged | 61,710 | Jul 28, 2026 |
| KESTRA PRIVATE WEALTH SERVICES, LLC | Increased | 61,710 | Apr 20, 2026 |
| Ikarian Capital, LLC | Unchanged | 51,793 | Aug 14, 2026 |
| IKARIAN CAPITAL, LLC | Unchanged | 51,793 | May 15, 2026 |
| RHUMBLINE ADVISERS | Increased | 30,529 | Aug 12, 2026 |
| XTX TOPCO LTD | Reduced | 18,629 | May 15, 2026 |
| RHUMBLINE ADVISERS | Increased | 18,366 | May 12, 2026 |
| XTX Topco Ltd | Reduced | 15,987 | Aug 14, 2026 |
| Philadelphia Investment Partners, LLC | Increased | 15,000 | Aug 14, 2026 |
| SmartHarvest Portfolios, LLC | New Position | 14,566 | Apr 21, 2026 |
| Lido Advisors, LLC | New Position | 14,341 | Aug 7, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 1, 2026